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Abstract
During my research I completed work on two separate projects.  First, I worked with cell lines 
generated from Drosophila melanogaster embryos and characterized them for specific cell type. 
Our lab has recently developed a new method of efficiently creating new Drosophila cell lines. 
With this approach, many new lines have been created, and I screened them with 
immunostaining for specific cell type.  Out of the 24 lines examined, I found examples of nerve, 
blood, and epithelial cell types.  The epithelial line may be useful for future analysis of the Egfr 
pathway through in vitro studies.  Second, I analyzed the Epidermal Growth Factor Receptor 
(Egfr) Pathway using the Drosophila wing as a model system.  Our lab has identified numerous 
potential targets of the pathway, including Sulfated (Sulf1), a 6-O-endosulfatase that modifies 
glucosamine residues in heparan-sulfated proteoglycans.  The role of Sufl1 and its interactions 
with the Egfr pathway ligand, Vein, were analyzed genetically.  In this thesis, these two projects 
will be treated as two separate sections.    
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Chapter 1
Analysis of Cell Types in Continuous Drosophila Cell Lines
Introduction
Cell culture has proven to be an extremely useful resource in research for analyzing 
biological functions and biochemical pathways.  Its utilization has lead to a better understanding 
of countless biological mechanisms and serves as an excellent complement to in vivo studies (for 
example, Banker and Cowan, 1977; Meuillet et al., 2000; Howlin et al., 2008).  Although cell 
culture has great potential, the creation of cell lines in Drosophila often proves difficult, and 
many potential lines fail to reach an immortal state.  Advances in mammalian cell culture have 
lead to effective methods for establishing and maintaining cell lines.  For instance, a technique 
often employed to maintain cells  in an immortal state involves the activation of  telomerase by 
expression of the human telomerase reverse transcriptase (hTERT) gene (for example, Hunag et 
al., 2007; Li et al., 2007) and the inhibition of tumor suppressors such as p53 and Rb with large T 
antigen (for example, Foddis et al., 2002; Yang et al., 2007).  
In contrast to mammalian cell culture, the development of Drosophila cell culture lags 
behind.  One reason for this is that researchers have lacked an efficient method of creating new 
lines.  Previously, Drosophila cell lines were obtained from primary cultures that spontaneously 
adopted an immortal cell fate (Schneider, 1972; Debec, 1978).  With the use of this approach, 
however, continuous cell lines were typically only produced from about one out of every ten 
cultures, and the process takes a long time (Simcox et al., 1985).   
Our lab has developed a new method of efficiently producing Drosophila cell lines. 
Expression of the conserved oncogene RasV12, a constitutively active form of Ras, significantly 
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increases the percent of cultures that result in continuous cell lines and greatly decreases the time 
required to establish the lines (Simcox et al., 2008a).  UAS-regulated constructs of the oncogene 
and the green fluorescent protein (GFP) were induced by expression of Act5C-Gal4.  Act5C, a 
cytoplasmic actin, drives the expression of Gal4, and as a result, also drives the expression of the 
UAS transgenes.  In addition to efficiently producing new cell lines, this method also allows for 
the generation of cell lines with a specific genotype.  In order to demonstrate this, cell lines were 
produced in which an RNAi transgene was used to silence the expression of warts (wts), a tumor 
suppressor gene.  Additionally, cell lines were created that contained a loss of function mutant 
form of the gene rumi, which encodes an O-glycosyltransferase and is required for Notch 
signaling in Drosophila (Acar et al., 2008; Simcox et al., 2008b).
With the use of this method many cell lines were produced including: 3 control lines 
(Act5C-Gal4; UAS-GFP), 8 RasV12 lines (Act5C-Gal4; UAS-GFP, UAS-RasV12), 8 RasV12; wtsRNAi 
lines (Act5C-Gal4; UAS-GFP, UAS-RasV12, UAS-wtsRNAi) , and 5 RasV12; rumi- (Act5C-Gal4; UAS-
RasV12, rumi-).  Within these cell lines, the majority of the cells had a spindle-shaped 
morphology; however, one control cell line was composed of circular shaped cells, and one 
RasV12; wtsRNAi line had an epithelial-like morphology.  The ability to produce Drosophila cell 
lines with a specific cell type would prove to be extremely valuable and would significantly 
advance the field.  In order to determine if this method yields cell lines of specific cell types, 
immunostaining was used to screen the cell lines with four cell specific antibodies to test for the 
presence of nerve (HRP) (Jackson immunoresearch ), muscle (dMef2) (Lilly et al., 1995), blood 
(H2) (Kurucz et al., 2003), and epithelial (D- E Cadherin) (Hybridoma Bank, Iowa) cell types.
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Methods
24 different cell lines were screened, which consisted of 3 control lines (Act5C-Gal4;  
UAS-GFP), 8 RasV12 lines (Act5C-Gal4; UAS-GFP, UAS-RasV12), 8 RasV12; wtsRNAi lines (Act5C-
Gal4; UAS-GFP, UAS-RasV12, UAS-wtsRNAi) , and 5 RasV12; rumi- (Act5C-Gal4; UAS-RasV12,  
rumi-).  Cells were plated on coverslips in multi-well cell culture plates or in multi-well slide 
chambers and were allowed to adhere for 15 minutes to 24 hours.  Cells were washed twice with 
1X PBS for 30 seconds, fixed with 4% paraformaldehyde in PBS for 20 minutes at room 
temperature, and then washed three times in 1X PBS for three minutes each.  Blocking solution 
(0.1% Triton X-100, 1% BSA, 1X PBS) was added for 15 minutes to block and permeabilize the 
cells.  Cells were incubated with primary antibody in blocking solution for 1 hour at room 
temperature.  Cells were washed three times in 1X PBS for 4 minutes and Rhodamine conjugated 
secondary antibodies (1:200) were added for 30 minutes at room temperature.  Cells were 
washed three times in 1X PBS for 4 minutes and mounted using Vectashield (Vector 
Laboratories).  Cells were photographed using a compound fluorescence microscope or a Zeiss 
510 META Laser Scanning Confocal microscope by Litty Paul.  The following  antibodies were 
used: HRP- Jackson immunoresearch (Rhodamine conjugated) 1:200, dMef2 (Rabbit) 1:500 
(Lilly et al., 1995), H2 antibody (Mouse) 1:10 (Kurucz et al., 2003), D- E Cadherin (Rat) 1:5 
(Hybridoma Bank, Iowa).  All of the secondary antibodies were from Jackson ImmunoResearch.
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Results and Discussion
Immunostaining was used to analyze the cell type of 24 different cell lines.  These cell 
lines included 3 control lines, 8 RasV12 lines, 8 RasV12; wtsRNAi lines, and 5 RasV12; rumi- lines.  The 
cell lines were screened with four different antibodies: HRP, dMef2, H2, and D E-Cadherin.  As 
predicted by the abundant spindle-shaped morphology, many of the cell lines remain in a 
presumably undifferentiated state; however, a few lines positive for cell markers were observed 
(Table 1). 
The HRP antibody tests for the presence of nerve cells within the cell cultures by binding 
to the terminal end of neurons, where it is subsequently transported back to the soma (cell body). 
Positive results with the HRP antibody were observed in 3 cell lines: 1wc, RasV12; rumi- line 1, 
RasV12; rumi- line 4,  and RasV12; rumi- line 8 (Table1).  The control line 1wc contained some cells 
that tested positive with HRP staining; however, the majority of the cells within the culture had 
negative results.  Most of the cells in this line have a circular shape morphology, which is 
inconsistent with differentiated nerve cells.  Three lines of the RasV12; rumi- cells also tested 
positive for HRP, including RasV12; rumi- line 4 (Figure 1B), and a large percentage of the cells 
within these cultures were positive for the marker.  Activation of the Notch signaling pathway 
requires the expression of rumi, which transfers glucose molecules onto the extracellular domain 
of the Notch protein, leading to the cleavage of the extracelluar domain.  In loss of function 
mutants of rumi, the Notch protein remains in an inactivated state within the cellular membrane 
(Stanley, 2008).  Furthermore, Drosophila embryos that lack Notch signaling have been shown to 
have an over proliferation of neural tissue (Korochkin et al., 1991).  In light of this, it is not too 
surprising that some of the RasV12; rumi- cell lines were positive for the neural cell marker.
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HRP dMef2 H2 E-Cad
1wc + + - -
8wc - + - -
c7 - + - -
Ras1 - + - -
Ras6 - + - -
Ras7 - + - -
Ras8 - + + -
Ras9 - + - -
Ras10 - + - -
Ras11 - + - -
Ras13 - + - -
Ras wts1 - + - -
Ras wts2 - + - -
Ras wts3 - + - -
Ras wts4 - + - -
Ras wts5 - + - -
Ras wts6 - + - -
Ras wts10 - + - -
Ras wtsE ND* + ND* +
Ras rumi1 + + ND* ND*
Ras rumi2 - + ND* ND*
Ras rumi4 + ND* ND* ND*
Ras rumi5 - + ND* ND*
Ras rumi8 + + ND* ND*
Table 1.  Results of immunostaining cell lines.  3 control (1wc, 8wc, and c7),  8  RasV12,  8 RasV12; wtsRNAi, and 5 
RasV12; rumi- cell lines were stained with four antibodies that test for the presence of nerve (HRP), muscle (dMef2), 
blood (H2), and epithelial (D E-Cadherin) cell types. 
*ND not determined. Cell line was not stained with the given antibody. 
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The dMef2 antibody tests for the presence of the Drosophila myocyte enhancer binding 
factor-2, which is a transcription factor expressed in skeletal, cardiac, and smooth muscle cell 
lineages of Drosophila embryos.  In early embryos, dMef2 is expressed in mesodermal  tissue, 
but in later embryos, expression is limited to the somatic muscle tissue.  Because of this, dMef2 
serves as both as a muscle tissue and mesodermal tissue marker (Lilly et al., 1995).  Somewhat 
surprisingly, every cell line tested showed positive results when stained with the dMef2 antibody, 
Figure 1. Cell lines show positive results with immunostaining.  (A) RasV12 line 10 expresses dMef2 suggesting 
that it is of mesodermal origin. (B) RasV12; rumi- line 4 expresses HRP indcating the cells express the neural marker. 
(C) RasV12 line 8 expresses H2 indicating that it may be a blood cell type. (D) Confocal image of RasV12; wtsRNAi  line 
E cells that have an epithelial-like morphology and expresses D E-Cadherin.
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which indicates that the cells have mesodermal origins.  RasV12 line 10 serves as a representative 
cell line, and its expression of dMef2 is shown (Figure 1A).  
The presence of blood cells was tested for with the H2 antibody.  H2 recognizes Hemese, 
a transmembrane protein found on Drosophila melanogaster blood cells (hemocytes). Expression 
of this protein is restricted to the surfaces of all types of hemocytes and hemopoetic organs 
(Kurucz et al., 2003).  RasV12 line 8 showed some positive results when stained with H2 (Figure 
1C), however, only a few cells within the culture showed this phenotype.
Finally, D E-Cadherin tests for the presence of epithelial cells by binding to cadherins 
(calcium dependent adhesion molecules) that are expressed on the cell surface of epithelial cells. 
Positive results were seen with D E-Cadherin expression in one cell line, RasV12; wtsRNAi line E 
(Figure 1D).  Because this line also has an epithelial-like morphology, it is believed to be a true 
epithelial cell line.   This cell line opens up many possibilities for future research in examining 
polarity.  While an epithelial cell line could serve as an excellent system to analyze the 
Epidermal Growth Factor Receptor pathway in vitro, the consitutively active Ras expressed by 
this line makes this RasV12; wtsRNAi line undesirable for such research.  However, an additional 
epithelial line has been created (not shown) with wtsRNAi alone, which could be used for Egfr 
anaylsis.    
Although this method has been shown to efficiently generate continuous Drosophila cell 
lines, it does not allow for the effective production of tissue specific lines.  Our lab is currently 
exploring new techniques to create lines of specific cell types.  For instance, our lab is working 
on the establishment of a muscle cell line using tissue specific induction of Gal4.  This would 
lead to a selective expression of Ras within these tissues, giving these cells a proliferative 
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advantage within the culture.  Also, a technique that would allow for reversible Ras expression is 
being investigated.  With this approach, Ras expression could be used to efficiently establish cell 
lines, and later be shut off to potentially allow for cell differentiation.
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Chapter 2
Analysis of the Epidermal Growth Factor Receptor Pathway 
in Drosophila melanogaster
Background
The EGF receptor and ligands
The Epidermal Growth Factor Receptor (Egfr) pathway is a highly conserved pathway 
that is essential throughout development for many biological processes, such as cell migration, 
differentiation, proliferation, and tissue patterning.  The Drosophila Egfr pathway consists of one 
dimerizing tyrosine kinase receptor and four ligands: Spitz, Keren, Gurken, and Vein.  Spitz, 
Keren, and Gurken are all activating ligands that are produced as transmembrane precursors, 
while Vein is a secreted activating ligand (see Freeman, 1998; Shilo 2003, 2005, for review). 
The primary activating ligand is Spitz, which is ubiquitously produced in an inactive 
form and retained in the Endoplasmic Reticulum (ER).  Activation of Spitz is highly regulated 
and requires processing from two proteins, Star and Rhomboid (see Schweitzer and Shilo, 1997, 
for review).  Star, which is also ubiquitously expressed, mediates the migration of Spitz from the 
ER to the Golgi apparatus, where it is cleaved by Rhomboid (Urban et al., 2001).  The activated 
Spitz protein is then transported to the cell surface and secreted.  During this process, Rhomboid 
serves as the limiting agent that regulates activation.  Ectopic expression of Rhomboid leads to 
excess Egfr activity in a wide variety of cell types (Golembo et al., 1996; Sturtevant et al., 1993). 
The other two transmembrane ligands, Keren and Gurken, are activated through a similar 
process.  The activation of Gurken is also highly regulated by Star and Rhomboid, but expression 
of Gurken is limited to the germ cells (see Schweitzer and Shilo, 1997, for review).  Keren 
resembles Spitz, however, the activation of Keren via Star and Rhomboid occurs with much less 
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regulation.  Rhomboid has been observed to cleave Keren in the absence of Star, and 
overexpression of Keren leads to hyperactive Egfr activity (Reich et al., 2002).  All of the 
transmembrane ligands retain a single EGF domain in their activated form following cleavage by 
Rhomboid (Schweitzer et al., 1995).  This EGF domain serves as the site of ligand-receptor 
binding (Schnepp et al., 1998).
In comparison with the other activating ligands,  less is known about the ligand Vein.  As 
a secreted activating ligand, Vein does not require any post-translational modification to reach an 
active state (Shilo et al., 2003).  In addition to an EGF domain, Vein also contains an 
immunoglobulin-like domain.  The presence of these two domains causes Vein to resemble 
vertebrate neuroregulins (Schnepp et al., 1996).  Also, when compared to Spitz, which is a very 
potent activator, Vein is a moderate activator of Drosophila Egfr signaling (Schnepp et al., 1998) 
that functions in both the developing embryo and the adult wing (Schnepp et al., 1998). 
Downstream Targets
Once activating ligands bind to the EGF receptor, the receptors dimerize and cross 
phosphorylate on Carboxy-terminal tyrosine residues (Schnepp et al. 1998).  Activation of these 
receptors leads to activation of many downstream target proteins.  The main route that the signal 
transduction proceeds is through the Ras/Raf/ERK cascade.  The Drosophila ERK rolled (rl) 
activates among many other proteins the transcription factors Pointed P1 and Pointed P2 
(Bergmann et al., 1998). Pointed P1 has been shown to activate the Egfr inhibitor argos.  In this 
way, argos acts in a negative feedback loop to regulate the activity of the Egfr pathway (Klein et 
al., 2004).  The Egfr pathway also has important roles in cell survival. rl has been shown to 
suppress the proapoptotic activity of head involution defective (hid) (Bergmann et al., 1997).  
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The Drosophila Wing
The Drosophila wing serves as a good model system for the study of the control of 
epidermal tissue patterning, shape, and size.  The wing is formed from an imaginal wing disc that 
originates from about 20 cells in the embryo that proliferate throughout the larval stage reaching 
50,000 cells in the late 3rd instar.  Throughout this proliferation phase, cells receive ordered 
signaling events and transcriptional regulation that determine the pattern of veins and intervein 
regions within the wing blade.  In Drosophila melanogaster, the wing consists of six longitudinal 
veins (L1-L6) and two transverse veins. (see Crozatier et al., 2004; de Celis, 2003, for review).
Early during development, the cells of the wing disc are divided into two distinct groups, 
the anterior and the posterior.  The anterior population is controlled by the transcription factor 
Cubitus interruptus (Ci), while the posterior is controlled by the expression of engrailed (en). 
During the late 3rd instar, expression of blistered (bs) marks the intervein regions, while the 
provein regions are marked by the expression of rhomboid.  The formation of each of the 
longitudinal veins requires separate signaling mechanisms, which all involve some signaling 
from the Egfr pathway.  
In the center of the wing, hedgehog (hh) plays a key role by activating numerous genes. 
knot (kn), a transcription factor activated by hh, activates bs in the L4/L3 intervein region and 
vein, a ligand from the Egfr pathway that is required for the formation of the L4 vein.  hh is also 
responsible for activating the iroquois gene complex (iro), which mediates the expression of the 
L3 vein by activating the vein determining genes rhomboid and Delta, which encodes a ligand in 
the Notch pathway.  Positioning of the L2 and L5 veins is influenced by the spalt complex, 
which is made up of two genes: spalt (sal) and spalt-related (salr). 
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Once the provein regions are established, signaling from both the Egfr and Notch 
pathways is required for vein formation.  Ligands of the Notch pathway, including Delta, are 
expressed in the provein regions.  These ligands activate the Notch pathway in neighboring cells, 
which results in the prevention of vein formation in these regions.  Notch activation also confines 
the proteins Star and Rhomboid in the provein region, leading to the activation of the Egfr 
ligands.  Egfr signaling prevents the expression of bs and allows for vein differentiation.  As a 
result, extra veins and gaps in the veins results from too much and too little Egfr activity, 
respectively (Schnepp et al., 1996).
Discovery of New Components in the Egfr Pathway
The highly conserved Egfr pathway is required for numerous biological mechanisms 
throughout development; however, many targets of the pathway remain unknown.  Through 
microarray analysis, our lab has discovered several potential targets of the pathway, including 
Sulfated (Sulf1).  Sulf1 encodes a 6-O-endosulfatase that modifies the glucosamine residues in 
heparan-sulfated proteoglycans.  The vertebrate homolog HSulf-1 has recently been shown to 
have been down-regulated in ovarian, breast, and other types of cancer cell lines (Narita et al., 
2007).
The role of Sulf1 and its interactions with the Egfr pathway were analyzed genetically, 
using the Drosophila wing as a model system.  Many stocks used in the screen were created by 
Jon P. Butchar.  These included Sulf1 overexpression transgenes and Sulf1 RNAi transgenes, as 
well as two recombinant lines: Sulf1 overexpression;en-Gal4 and Sulf1 RNAi;en-Gal4.  Initial 
results from Jon P. Butchar indicated that Sulf1 may act in a negative feedback loop within the 
Egfr pathway through inhibition of the ligand Vein.  My goal was to test these initial findings. 
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Methods
All crosses were carried out at 25°C and 29°C.  The following Gal4 and UAS constructs 
were used: UAS-Vn1.1 (Schnepp et al., 1996), 71B-GAL4 (Brand and Perrimon, 1993), Actin5C-
Gal4 (Act5C-Gal4), engrailed-Gal4 (en-Gal4) (Aza-Blanc et al., 1997), optomotor-blind-Gal4 
(omb-Gal4) (Cook et al., 2004), Sulf1 overexpression lines 1-5, Sulf1 RNAi line 2, Sulf1 RNAi 
line 9, Sulf1/CG6725 Vienna RNAi 37361, Sulf1/CG6725 Vienna RNAi 37362, Sulf1/CG6725 
Vienna RNAi 45954.  Two recombinants were created by Jon P. Butchar: Sulf1 overexpression; 
en-Gal4/Cyo and Sulf1 RNAi; en-Gal4/Cyo.
Virgins of each of the Sulf1 overexpression lines and the Sulf1 RNAi lines were crossed 
with males from all four Gal4-drivers to drive expression of the Sulf1 transgenes.  Additionally, 
UAS-Vn1.1 virgins were crossed with males from the two recombinants (Sulf1 overexpression;  
en-Gal4/Cyo and Sulf1 RNAi; en-Gal4/Cyo) as well as en-Gal4 in order to analyze the 
interactions of Sulf1 and the ligand vn.
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Results and Discussion
The role of Sulf1 and its interactions with the Egfr ligand vn were analyzed with the use 
of the Drosophila wing as a model system.  Because the patterning and differentiation of veins on 
the wings is partially controlled through the Egfr pathway, induced changes in vein patterning by 
Sulf1 could be a result of modulating the Egfr pathway.
Phenotypic Effects of Sulf1 Knockdown and Overexpression
Reverse genetics with transgenes was used to disrupt the wildtype functioning of Sulf1 in 
order to analyze its role during development.  Expression was perturbed by overexpressing a 
Sulf1 cDNA (UAS-Sulf1OE) and by inhibiting Sulf1 expression with RNAi (UAS-Sulf1 RNAi). 
The GAL4-UAS system (Brand and Perrimon, 1993) was used to drive the expression of these 
Sulf1 transgenes with various drivers: en-Gal4, which is expressed in the posterior region of the 
wing; omb-Gal4, which is expressed in the early wing; 71B-Gal4, which is expressed in the late 
wing, and Act5C-Gal4, which is expressed ubiquitously.  
Overexpression of Sulf1 with en-Gal4 (en-Gal4; UAS-Sulf1OE) gave no additional 
phenotypes beyond the expression of the en-Gal4 driver alone.  About a quarter of en-Gal4 flies 
lose expression of the anterior crossvein (Table 2).  Knockdown of Sulf1 with Sulf1 RNAi (UAS-
Sulf1 RNAi) appeared to suppress the phenotype seen in en-Gal4 flies, and additionally, a small 
fraction also showed an extra vein phenotype (Table 2). 
Sufl1 overexpression (UAS-Sulf1OE) and knockdown of Sulf1 (UAS-Sulf1 RNAi) also 
showed no extra phenotypes with omb-Gal4 than those seen with expression of the omb-Gal4 
activator with yw.  Flies expressing omb-Gal4 showed extra veins, as well as a loss of tissue at 
the posterior end of the wing  (Table 2).
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Additionally, overexpression of Sulf1 (UAS-Sulf1OE) again showed no extra phenotypes 
with 71B-Gal4 other than those seen with expression of the 71B-Gal4 driver alone.  Flies 
expressing 71B-Gal4 were observed to have extra anterior crossveins (Table 2).  Knockdown of 
Sulf1 with Sulf1 RNAi expressed with 71B-Gal4 (71B-Gal4; UAS-Sulf1 RNAi) seemed to 
suppress the extra vein phenotype (Table 2).
 Currently, analysis of Sulf1 overexpression (UAS-Sulf1OE) and knockdown of Sulf1  
(UAS-Sulf1 RNAi) with Act5C-Gal4 is still in progress.
Genotype % Viability Observed Phenotype % with Phenotype
en-Gal4; Sulf1RNAi 100 Extra veins 8
en-Gal4; Sulf1 OE 100 Missing anterior crossvein 14
en-Gal4 100 Missing anterior crossvein 25
omb-Gal4; Sulf1 RNAi 92 Loss of tissue and extra veins 84
omb-Gal4; Sulf1 OE 78 Loss of tissue and extra veins 75
omb-Gal4; yw 100 Loss of tissue and extra veins 100
71B-Gal4; Sulf1 RNAi 100 No phenotype NA*
71B-Gal4; Sulf1 OE 100 Extra anterior crossveins 10
71B-Gal4 100 Extra anterior crossveins 18
Act5C-Gal4; Sulf1 RNAi In Progress
Act5C-Gal4; Sufl1 OE In Progress
Act5C-Gal4/ TM6,Tb,Hu In Progress
Table 2. RNAi and overexpression of Sulf1. Sulf1 overexpression with en-Gal4, omb-Gal4, and 71B-Gal4 showed 
no additional phenotypes beyond the expression of the drivers alone.  Sulf1 RNAi with omb-Gal4 also did not show 
extra phenotypes other than those observed with expression of omb-Gal4 with yw.  Knockdown of Sulf1 with Sulf1  
RNAi expressed with en-Gal4 and 71B-Gal4 appeared to suppress the phenotype seen in expression of the drivers 
alone, and additionally,  Sulf1 RNAi  with  en-Gal4 showed an extra vein phenotype.  Currently, analysis with the 
ubiquitous driver Act5C is still in progress.
*NA not applicable  
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These results indicate that the initial findings of Jon P. Butchar could not be substantiated when 
the analysis was expanded to include additional lines of Sulf1 overexpression (UAS-Sulf1OE) 
and Sulf1 RNAi (UAS-Sulf1 RNAi).  After analyzing the controls, many of the phenotypes that 
were initially thought to be the result of Sulf1 were shown to be caused by expression of the Gal4 
drivers alone.
Interactions between Sulf1 and Vein
The interactions between Sulf1 and vn were analyzed through genetic tests.  Lethality in 
the pupal stage is observed when the UAS-regulated construct of vn (UAS-Vn1.1) was under the 
control of the driver en-Gal4 (Fig. 3).  However, Jon P. Butchar reported that when the flies also 
overexpressed Sulf1, they were rescued.  Although the flies were rescued, they were not restored 
to wildtype due to the extra vein and blisters phenotype that was observed (Fig. 3).  I am 
currently repeating these crosses.  
Control (en-Gal4) Sulf1 RNAi; en-Gal4 Sulf1 overexpression; en-Gal4
UAS-
Vn1.1
Lethal Lethal
Figure 3. Interactions of Sulf1 and Vein. Figure by Jon P. Butchar.  Expression of UAS-Vn1.1 driven by en-Gal4 
as well as  Sulf1 RNAi; en-Gal4 result in lethality at 25°C.  Overexpression of  Sulf1 rescues this lethality, but the 
wings were not wildtype as extra veins and blisters were observed. 
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Future Directions
If I can confirm the rescue of Vn1.1; en-Gal4 with overexpression of Sulf1, future studies 
could analyze how Sulf1 and Vn1.1 physically interact.  One possible mechanism for the 
interaction between Sulf1 and vn is through the Ig-like domain of Vein.  In vertebrates, it has 
been demonstrated that the Ig-like domain of neuregulins, such as neuregulin-1, is involved in 
their binding to heparan-sulfated proteoglycans (Pankonin, 2005).  This suggests that Vein may 
bind to heparan-sulfated proteoglycans through its Ig-like domain, and the strength of this 
interaction may be regulated by the ability of Sulf1 to remove the 6-O sulfate from the 
proteoglycans.
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